Abacus Life, Inc. (NASDAQ:ABL – Get Free Report) saw unusually-strong trading volume on Monday . Approximately 15,555 shares were traded during trading, a decline of 68% from the previous session’s volume of 47,928 shares.The stock last traded at $8.87 and had previously closed at $8.65.
Analysts Set New Price Targets
A number of analysts have weighed in on ABL shares. B. Riley restated a “buy” rating and set a $15.00 target price (down previously from $16.00) on shares of Abacus Life in a report on Monday, June 24th. Piper Sandler assumed coverage on Abacus Life in a research report on Wednesday, June 26th. They set an “overweight” rating and a $12.00 price target on the stock. Finally, B. Riley Financial reduced their price target on Abacus Life from $16.00 to $15.00 and set a “buy” rating on the stock in a research report on Monday, June 24th.
Check Out Our Latest Analysis on ABL
Abacus Life Stock Performance
Abacus Life (NASDAQ:ABL – Get Free Report) last released its earnings results on Monday, May 13th. The company reported $0.11 earnings per share (EPS) for the quarter. Abacus Life had a return on equity of 4.96% and a net margin of 0.11%. The firm had revenue of $21.49 million for the quarter. As a group, sell-side analysts forecast that Abacus Life, Inc. will post 0.5 earnings per share for the current year.
Hedge Funds Weigh In On Abacus Life
Several hedge funds have recently made changes to their positions in ABL. Barclays PLC acquired a new position in shares of Abacus Life in the 3rd quarter valued at $47,000. Inscription Capital LLC acquired a new position in shares of Abacus Life in the 1st quarter valued at $137,000. Finally, Quarry LP acquired a new stake in Abacus Life during the 4th quarter worth about $463,000.
Abacus Life Company Profile
Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.
Featured Articles
- Five stocks we like better than Abacus Life
- How Can Investors Benefit From After-Hours Trading
- RXO Shares Surge Following New Acquisition Deal
- 3 Best Fintech Stocks for a Portfolio Boost
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- What Is WallStreetBets and What Stocks Are They Targeting?
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for Abacus Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abacus Life and related companies with MarketBeat.com's FREE daily email newsletter.